1h Free Analyst Time
Global Tissue Diagnostics Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the global tissue diagnostics market and it is poised to grow by USD 2.56 bn during 2020-2024, progressing at a CAGR of 9% during the forecast period. This report on the global tissue diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by technological advances in tissue diagnostic techniques. In addition, increasing demand for personalized medicines is anticipated to boost the growth of the global tissue diagnostics market as well.
Market Segmentation
The global tissue diagnostics market is segmented as below:
Technology:
- Advanced and special stainings
- Routine stainings
- Digital pathology and workflow
Product:
- Tissue diagnostic consumables
- Tissue diagnostic instruments
End-user:
- Hospitals
- Diagnostic laboratories
- Others
Geographic segmentation:
- North America
- APAC
- Europe
- South America
- MEA
Key Trends for global tissue diagnostics market growth
This study identifies increasing demand for personalized medicines as the prime reasons driving the global tissue diagnostics market growth during the next few years.
Prominent vendors in global tissue diagnostics market
The publisher provides a detailed analysis of around 25 vendors operating in the global tissue diagnostics market, including some of the vendors such as Abbott Laboratories, Agilent Technologies Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., PerkinElmer Inc., QIAGEN N.V., Sakura Finetek Japan Co. Ltd., Siemens Healthineers AG and Thermo Fisher Scientific Inc..
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global tissue diagnostics market: Abbott Laboratories, Agilent Technologies Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., PerkinElmer Inc., QIAGEN N.V., Sakura Finetek Japan Co. Ltd., Siemens Healthineers AG and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing demand for personalized medicines."
According to the report, one of the major drivers for this market is the technological advances in tissue diagnostic techniques.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips N.V.
- PerkinElmer Inc.
- QIAGEN N.V.
- Sakura Finetek Japan Co. Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.